COMMUNIQUÉS West-GlobeNewswire

Profound Medical to Release Second Quarter 2019 Financial Results on August 14 – Conference Call to Follow
30/07/2019
TORONTO, July 30, 2019 (GLOBE NEWSWIRE) -- Profound Medical Corp. (TSX:PRN; OTCQX:PRFMF) (“Profound” or the “Company”), the only company to provide customizable, incision-free therapies which combine real-time Magnetic [...]
Voyager Therapeutics to Present at Upcoming Investor Conferences in August 2019
30/07/2019
CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
Amedisys to Acquire Home Health Regulatory Assets Expanding Access in New York
30/07/2019
BATON ROUGE, La., July 30, 2019 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), America’s leading independent home health, hospice and personal care company, has signed a definitive agreement to acquire regulatory [...]
EyePoint Pharmaceuticals Presents Positive Data Showcasing YUTIQ® at the 37th Annual Scientific Meeting of the American Society of Retina Specialists
30/07/2019
WATERTOWN, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today [...]
The Cooper Companies Announces Release Date for Third Quarter 2019
30/07/2019
PLEASANTON, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE: COO) today announced it will release third quarter 2019 financial results on Thursday, August 29, 2019, at 4:15 PM ET. Following [...]
Dova Pharmaceuticals to Announce Second Quarter 2019 Financial Results on August 6, 2019
30/07/2019
DURHAM, N.C., July 30, 2019 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA) will host a conference call on Tuesday, August 6, 2019 at 9:00 a.m. ET to discuss second quarter 2019 financial results and [...]
InspireMD to Report Second Quarter 2019 Financial Results and Provide Business Update on Tuesday, August 6
30/07/2019
Management to host conference call and webcast at 8am ET TEL AVIV, Israel, July 30, 2019 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the [...]
Prothena to Report Second Quarter 2019 Financial Results on August 6
30/07/2019
DUBLIN, Ireland, July 30, 2019 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq:PRTA), a clinical-stage neuroscience company, will announce financial results for the second quarter and first six months of 2019 on [...]
ORYZON Reports Financial Results and Corporate Update for the First Half Ended June 30, 2019
30/07/2019
MADRID, Spain and CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a public clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies [...]
BioTelemetry, Inc. Reports Second Quarter 2019 Financial Results
30/07/2019
Exceeds Expectations Achieves Record Revenue and Adjusted EBITDA MALVERN, Pa., July 30, 2019 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of [...]
Editas Medicine to Host Conference Call Discussing Second Quarter 2019 Results and Corporate Update
30/07/2019
CAMBRIDGE, Mass., July 30, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, today announced that it will host a conference call and webcast on Tuesday, August 6, 2019, at [...]
Aclaris Therapeutics Announces Phase 2 Clinical Trial of ATI-501 Oral in Patients with Alopecia Areata Met Primary Endpoint
30/07/2019
ATI-501 achieved statistically significant improvement over placebo in several measures of hair growth, including the primary endpoint and certain secondary endpoints of the trial. ATI-501 was generally well-tolerated [...]
Alder BioPharmaceuticals® to Host Conference Call to Discuss Second Quarter 2019 Financial and Operating Results
30/07/2019
BOTHELL, Wash., July 30, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (NASDAQ: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Alphatec Holdings, Inc. Announces Proposed Public Offering of Common Stock
30/07/2019
CARLSBAD, Calif., July 30, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today [...]
T2 Biosystems Reports Second Quarter 2019 Financial Results and Provides Corporate Update
30/07/2019
Announces Two Financing Agreements to Potentially Provide up to $60 Million of Additional Capital; Reducing Cash Burn by 30% by Q4 2019 Achieved $1.8 Million in Total Revenue and Secured 12 New T2Dx® Instrument [...]
Rheumatology Leaders Applaud Updates to Evaluation and Management Codes in CMS 2020 Physician Fee Schedule Proposed Rule
30/07/2019
Proposed Coding Changes Recognize Value of Time Spent with Complex Patients Atlanta, July 30, 2019 (GLOBE NEWSWIRE) -- WASHINGTON, D.C. – The American College of Rheumatology (ACR) today applauded the Centers for [...]
CV Sciences, Inc. Announces Expanded Distribution Partnership With The Kroger Co.
30/07/2019
PlusCBD™ Oil Topicals Now Available at 1,350 Kroger Stores SAN DIEGO, July 30, 2019 (GLOBE NEWSWIRE) -- CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent supplier and [...]
Sensus Healthcare to Host Second Quarter 2019 Financial Results and Business Update Conference Call on August 8, 2019
30/07/2019
BOCA RATON, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological [...]
Update - Nephros Announces Second Quarter 2019 Financial Results Conference Call and Record Revenue of Over $1 Million in July
30/07/2019
SOUTH ORANGE, NJ, July 30, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nephros, Inc. (OTCQB: NEPHD), a commercial-stage company that develops and sells high performance water purification products to the medical device [...]

Pages